Skip to main content

Advertisement

Table 4 Associations between listing of CKD on problem list with guideline-driven processes of carea

From: Validating laboratory defined chronic kidney disease in the electronic health record for patients in primary care

  Outcome Model 1 Model 2
Problem List CKD Albuminuria test ordered Odds Ratio Odds Ratio
N (%) (95% C.I.) (95% C.I.)
 No = 932 288 (30%) Ref Ref
 Yes = 679 472 (57%) 2.94 (2.39–3.62) † 2.83 (2.17–3.70) †
Problem List CKD Parathyroid hormone test ordered
 No = 932 109 (12%) Ref Ref
 Yes = 679 400 (49%) 6.94 (5.40–8.92) † 5.03 (3.87–6.54) †
Problem List CKD Phosphorus test ordered
 No = 932 484 (51%) Ref Ref
 Yes = 679 601 (73%) 2.24 (1.81–2.77) † 1.60 (1.27–2.01) †
Problem List CKD Vitamin D test ordered
 No = 932 446 47% Ref Ref
 Yes = 679 573 70% 2.66 (2.16–3.27) † 2.35 (1.88–2.93) †
Problem List CKD ACE/ARB prescription
 No = 932 543 (57%) Ref Ref
 Yes = 679 570 (69%) 1.63 (1.32–2.01) † 1.21 (0.94–1.55) †
Problem List CKD Statin prescription
 No = 932 565 (60%) Ref Ref
 Yes = 679 600 (73%) 1.91 (1.53–2.37) † 1.56 (1.21–2.02) †
  1. aCharacteristics of patients included in process of care analyes, based on data from 01/01/2014 to 12/31/2015
  2. Model 1 includes age, sex, race, and ethnicity
  3. Model 2 adds each patient’s earliest 2nd qualifying eGFR (15–59.999 mL/min/1.73 m2) and comorbidities (diabetes mellitus, cerebrovascular disease, congestive heart failure, hypertension, and coronary artery disease)
  4.  = p < 0.05